388 Imetelstat sodium (GRN163L), a telomerase inhibitor: tolerability, pharmacokinetics and pharmacodynamic activity using an intermittent once every four weeks dosing schedule in patients with advanced solid tumors
Ratain M, Kelsey S, Janisch L, Smith J, Go N, Lin T, Maitland M, Kindler H, LoRusso P. 388 Imetelstat sodium (GRN163L), a telomerase inhibitor: tolerability, pharmacokinetics and pharmacodynamic activity using an intermittent once every four weeks dosing schedule in patients with advanced solid tumors. European Journal Of Cancer Supplements 2010, 8: 123. DOI: 10.1016/s1359-6349(10)72095-4.Peer-Reviewed Original Research